Skip to main content
Thorax logoLink to Thorax
. 1998 Mar;53(3):197–199. doi: 10.1136/thx.53.3.197

Gene therapy for cystic fibrosis: which postman, which box?

P Middleton 1, E Alton 1
PMCID: PMC1745161  PMID: 9659356

Abstract

Since 1989 when the gene responsible for cystic fibrosis was cloned and designated the cystic fibrosis transmembrane conductance regulator (CFTR) gene, considerable progress has been made in the development of gene therapy for this disease. Clinical trials have already been performed using cationic liposome and adenoviral based gene transfer systems, measuring the safety and efficacy of this new form of treatment, with variable results to date. These two approaches and the current progress in airway gene delivery are discussed.



Full Text

The Full Text of this article is available as a PDF (86.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alton E. W., Middleton P. G., Caplen N. J., Smith S. N., Steel D. M., Munkonge F. M., Jeffery P. K., Geddes D. M., Hart S. L., Williamson R. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet. 1993 Oct;5(2):135–142. doi: 10.1038/ng1093-135. [DOI] [PubMed] [Google Scholar]
  2. Caplen N. J., Alton E. W., Middleton P. G., Dorin J. R., Stevenson B. J., Gao X., Durham S. R., Jeffery P. K., Hodson M. E., Coutelle C. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med. 1995 Jan;1(1):39–46. doi: 10.1038/nm0195-39. [DOI] [PubMed] [Google Scholar]
  3. Crystal R. G., McElvaney N. G., Rosenfeld M. A., Chu C. S., Mastrangeli A., Hay J. G., Brody S. L., Jaffe H. A., Eissa N. T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994 Sep;8(1):42–51. doi: 10.1038/ng0994-42. [DOI] [PubMed] [Google Scholar]
  4. Dorin J. R., Farley R., Webb S., Smith S. N., Farini E., Delaney S. J., Wainwright B. J., Alton E. W., Porteous D. J. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 1996 Sep;3(9):797–801. [PubMed] [Google Scholar]
  5. Ferkol T., Perales J. C., Eckman E., Kaetzel C. S., Hanson R. W., Davis P. B. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J Clin Invest. 1995 Feb;95(2):493–502. doi: 10.1172/JCI117690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gershon H., Ghirlando R., Guttman S. B., Minsky A. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry. 1993 Jul 20;32(28):7143–7151. doi: 10.1021/bi00079a011. [DOI] [PubMed] [Google Scholar]
  7. Johnson L. G., Olsen J. C., Sarkadi B., Moore K. L., Swanstrom R., Boucher R. C. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet. 1992 Sep;2(1):21–25. doi: 10.1038/ng0992-21. [DOI] [PubMed] [Google Scholar]
  8. Knowles M. R., Hohneker K. W., Zhou Z., Olsen J. C., Noah T. L., Hu P. C., Leigh M. W., Engelhardt J. F., Edwards L. J., Jones K. R. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 1995 Sep 28;333(13):823–831. doi: 10.1056/NEJM199509283331302. [DOI] [PubMed] [Google Scholar]
  9. Middleton P. G., Caplen N. J., Gao X., Huang L., Gaya H., Geddes D. M., Alton E. W. Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth. Eur Respir J. 1994 Mar;7(3):442–445. doi: 10.1183/09031936.94.07030442. [DOI] [PubMed] [Google Scholar]
  10. Middleton P. G., Geddes D. M., Alton E. W. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J. 1994 Nov;7(11):2050–2056. [PubMed] [Google Scholar]
  11. Yang Y., Nunes F. A., Berencsi K., Gönczöl E., Engelhardt J. F., Wilson J. M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet. 1994 Jul;7(3):362–369. doi: 10.1038/ng0794-362. [DOI] [PubMed] [Google Scholar]
  12. Zabner J., Couture L. A., Gregory R. J., Graham S. M., Smith A. E., Welsh M. J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell. 1993 Oct 22;75(2):207–216. doi: 10.1016/0092-8674(93)80063-k. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES